Assessing the Financial Burden Associated With Treatment Options for Resectable Pancreatic Cancer.

ABSTRACT:

Objective

The aim of this study is to assess the financial burden associated with treatment options for resectable pancreatic cancer.

Background

As the volume of cancer care increases in the United States, there is growing interest among both clinicians and policy-makers to reduce its financial impact on the healthcare system. However, costs relative to the survival benefit for differing treatment modalities used in practice have not been described.

Methods

Patients undergoing resection for pancreatic cancer were identified in the Truven Health MarketScan database. Associations between chemoradiation therapies and survival were performed using parameterized multivariable accelerated failure time models. Median payments over time were calculated for surgery, chemoradia

SUBMITTER: Cerullo M 

PROVIDER: S-EPMC7385922 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature